Retraction Note: A mechanistic model of the neural entropy increase elicited by psychedelic drugs

Retraction Note: A mechanistic model of the neural entropy increase elicited by psychedelic drugs

Bibliographic Details
Main Authors:	Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas, Robin Carhart‑Harris, Yonatan Sanz Perl, Enzo Tagliazucchi, Rodrigo Cofre
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-20093-y

Similar Items

A whole-brain model of the neural entropy increase elicited by psychedelic drugs
by: Rubén Herzog, et al.
Published: (2023-04-01)

Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
by: Enzo Tagliazucchi, et al.
Published: (2022-03-01)

Whole-Brain Models to Explore Altered States of Consciousness from the Bottom Up
by: Rodrigo Cofré, et al.
Published: (2020-09-01)

Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
by: Josephine Cruzat, et al.
Published: (2022-01-01)

Psychedelics alter metaphysical beliefs
by: Christopher Timmermann, et al.
Published: (2021-11-01)

Psychedelics and schizophrenia: Distinct alterations to Bayesian inference
by: Hardik Rajpal, et al.
Published: (2022-11-01)

Psychedelics, Meditation, and Self-Consciousness
by: Raphaël Millière, et al.
Published: (2018-09-01)

The entropic brain:A theory of conscious states informed by neuroimaging research with psychedelic drugs
by: Robin Lester Carhart-Harris, et al.
Published: (2014-02-01)

Associations between lifetime classic psychedelic use and cardiometabolic diseases
by: Otto Simonsson, et al.
Published: (2021-07-01)

Decreased directed functional connectivity in the psychedelic state
by: Lionel Barnett, et al.
Published: (2020-04-01)

The therapeutic potential of psychedelic drugs: past, present and future
by: Carhart-Harris, R, et al.
Published: (2017)

Self-blinding citizen science to explore psychedelic microdosing
by: Balázs Szigeti, et al.
Published: (2021-03-01)

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
by: Julia Bornemann, et al.
Published: (2021-11-01)

Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology
by: Shinozuka, K, et al.
Published: (2024)

Case analysis of long-term negative psychological responses to psychedelics
by: Rebecka Bremler, et al.
Published: (2023-09-01)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
by: Balázs Szigeti, et al.
Published: (2023-07-01)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
by: Leor Roseman, et al.
Published: (2018-01-01)

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
by: Federico Zamberlan, et al.
Published: (2018-11-01)

Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality
by: Brandon Weiss, et al.
Published: (2021-11-01)

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
by: Rita Kočárová, et al.
Published: (2021-07-01)

A Comparison of the Maximum Entropy Principle Across Biological Spatial Scales
by: Rodrigo Cofré, et al.
Published: (2019-10-01)

Associations between lifetime classic psychedelic use and cardiometabolic diseases
by: Simonsson, O, et al.
Published: (2021)

The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports
by: Camila Sanz, et al.
Published: (2018-01-01)

Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
by: Enzo Tagliazucchi, et al.
Published: (2021-11-01)

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations
by: Emma Eckernäs, et al.
Published: (2022-12-01)

Corrigendum: The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports
by: Camila Sanz, et al.
Published: (2018-04-01)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
by: James B. Close, et al.
Published: (2021-09-01)

Psychedelics and sexual functioning: a mixed-methods study
by: Tommaso Barba, et al.
Published: (2024-02-01)

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex
by: Manesh Girn, et al.
Published: (2022-08-01)

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health
by: Sam Gandy, et al.
Published: (2020-12-01)

The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study
by: Grant Jones, et al.
Published: (2024-03-01)

Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use
by: Sebastian Hübner, et al.
Published: (2021-07-01)

Scaling of whole-brain dynamics reproduced by high-order moments of turbulence indicators
by: Yonatan Sanz Perl, et al.
Published: (2023-09-01)

Strength-dependent perturbation of whole-brain model working in different regimes reveals the role of fluctuations in brain dynamics.
by: Yonatan Sanz Perl, et al.
Published: (2022-11-01)

The INSIDEOUT framework provides precise signatures of the balance of intrinsic and extrinsic dynamics in brain states
by: Gustavo Deco, et al.
Published: (2022-06-01)

Association between lifetime classic psychedelic use and hypertension in the past year
by: Simonsson, O, et al.
Published: (2021)

Biophysical models applied to dementia patients reveal links between geographical origin, gender, disease duration, and loss of neural inhibition
by: Sebastian Moguilner, et al.
Published: (2024-04-01)

Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
by: Thomas F. Varley, et al.
Published: (2020-10-01)

Predicting Responses to Psychedelics: A Prospective Study
by: Eline C. H. M. Haijen, et al.
Published: (2018-11-01)

Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework
by: Emma Eckernäs, et al.
Published: (2023-10-01)